The Toxicity of Soman in the African Green Monkey (Chlorocebus aethiops)

REFERENCES

• Adams J. E., III, Bodor G. S., Davila-Roman V. G., Delmez J. A., Apple F. S., Fred S., Ladenson J. H., Jaffe A. S. Myocardial injury/infarction: cardiac troponin I: a marker with high specificity for cardiac injury. Circulation 1993; 88(1)101–106
   PubMed Web of Science ®Google Scholar
• Adams N. L. The intramuscular lethality of soman (GD) in the cynomolgus monkey. 1990, USAMRICD-TR-90–06 US Army Medical Research Institute of Chemical Defense, Aberdeen Proving Ground, MD, AD A224887.
   Google Scholar
• Adams N. L., von Bredow J., de Vera H. V. Intramuscular lethality of GD (soman) in the rhesus monkey. 1976, Edgewood Arsenal Technical Report EB-TR-7603 Aberdeen Proving Ground, MD, AD A026821.
   Google Scholar
• Anzueto A., Berdine G. G., Moore G. T., Gleiser C., Johnson D., White C. D., Johanson W. G. Pathophysiology of soman intoxication in primates. Toxicol. Appl. Pharmacol. 1986; 86: 56–68
   PubMed Web of Science ®Google Scholar
• Artenstein A. W., Hicks C. B., Goodwin B. S., Hilliard J. K. Human infection with B virus following a needlestick injury. Rev. Infect. Dis. 1991; 13: 288–291
   PubMedGoogle Scholar
• Baze W. B. Soman-induced morphological changes: an overview in the nonhuman primate. J. Appl. Toxicol. 1993; 13: 173–177
   PubMed Web of Science ®Google Scholar
• Britt J. O., Martin J. L., Okerberg C. V., Dick E. J. Histopathologic changes in the brain, heart, and skeletal muscle of rhesus macaques, ten days after exposure to soman (an organophosphorus nerve agent). Comp. Med. 2000; 50: 133–139
   PubMed Web of Science ®Google Scholar
• Busker R. W., Zijlstra J. J., Philippens I. H. C. H. M., Groen B., Melchers B. P. C. Comparison of the efficacy of single or repeated HI-6 treatment following soman poisoning in guinea pigs and marmoset monkeys. Toxicology 1996; 112: 183–194
   PubMed Web of Science ®Google Scholar
• Carpentier P., Foquin A., Dorandeu F., Lallement G. Delta activity as an early indicator for soman-induced brain damage: a review. Neurotoxicology 2001; 22(3)299–315
   PubMed Web of Science ®Google Scholar
• Cummins P., Perry S. V. Troponin I from human skeletal and cardiac muscles. Biochem. J. 1978; 171: 251–259
   PubMed Web of Science ®Google Scholar
• Davenport D. S., Johnson D. R., Holmes G. P., Jewett D. A., Ross S. C., Hilliard J. K. Diagnosis and management of human B virus (Herpesvirus simiae) infections in Michigan. Clin. Infect. Dis. 1994; 19: 33–41
   PubMed Web of Science ®Google Scholar
• DeCandole C. A., Douglas W. W., Evans C. L., Spencer K. E., Torrance R. W., Wilson K. M. The failure of respiration in death by anticholinesterase poisoning. Br. J. Pharmacol. 1953; 8: 466–475
   Web of Science ®Google Scholar
• DeCandole C. A., McPhail M. K. Sarin and paraoxon antagonism in different species. Can. J. Biochem. 1957; 35: 1071–1083
   PubMedGoogle Scholar
• Dirnhuber P., French M. C., Green D. M., Leadbeater L., Stratton J. A. The protection of primates against soman poisoning by pretreatment with pyridostigmine. J. Pharm. Pharmacol. 1979; 31: 295–299
   PubMed Web of Science ®Google Scholar
• Dixon R. L. Problems in extrapolating toxicity data for laboratory animals to man. Environ. Health Perspect. 1976; 13: 43–50
   PubMed Web of Science ®Google Scholar
• Dixon W. J., Massey F. J. Introduction to Statistical Analysis. McGraw-Hill, New York 1981
   Google Scholar
• D'Mello G. D., Scott E. A. M. Toxicity of sarin and GD in marmosets (Callithrix jacchus). 1986, Technical Paper 458 Chemical Defense Establishment, Porton Down, United Kingdom.
   Google Scholar
• Fairbanks L. Alternative old world primate models for non-AIDS research; African green monkeys (vervets). Rhesus Monkey Demands in Biomedical Research; a Workshop Report. Research Resources Information Center, Bethesda, MD 2002, National Academy of Sciences
   Google Scholar
• Feaster S. R., Gordon R. K., Doctor B. P., Clark C. C., Maxwell D. M., Lenz D. E. Unprocessed whole blood cholinesterase levels: WRAIR protocol development and validation. USAMRMC Bioscience Review 2000; 3: 1099–1107
   Google Scholar
• Fukuyama G. S., Askwich W. E. 1963, Unpublished data cited in Adams et al. (1976) and Dirnhuber et al. (1979)
   Google Scholar
• Holmes G. P., Hilliard J. K., Klontz K. C., Rupert A. H., Schindler C. M., Parish E., Griffin D. G., Ward G. S., Bernstein N. D., Bean T. W. B virus (Herpesvirus simiae) infection in humans: epidemiologic investigation of a cluster. Ann. Intern. Med. 1990; 112: 833–839
   PubMed Web of Science ®Google Scholar
• Johnson R. P., Gold A. J., Freedman G. Comparative lung-airway resistance and cardiovascular effects in dogs and monkeys following parathion and sarin intoxication. Amer. J. Physiol. 1958; 192: 581–584
   PubMedGoogle Scholar
• Katrukha A. Antibody selection strategies in cardiac troponin assays. Cardiac Markers Second edition, AH.B. Wu. Humana Press, New Jersey 2003
   Google Scholar
• Koplovitz I., Gresham V. C., Dochterman L. W., Kaminskis A., Stewart J. R. Evaluation of the toxicity, pathology, and treatment of cyclohexylmethylphosphonofluoridate (CMPF) poisoning in rhesus monkeys. Arch Toxicol. 1992; 66: 622–628
   PubMed Web of Science ®Google Scholar
• Krasovskii G. N. Extrapolation of experimental data from animals to man. Environ. Health Perspect. 1976; 13: 51–58
   PubMed Web of Science ®Google Scholar
• Krummer S., Thiermann H., Worek F., Eyer P. Equipotent cholinesterase reactivation in vitro by the nerve agent antidotes HI 6 dichloride and HI 6 dimethanesulfonate. Arch. Toxicol. 2002; 76(10)589–595
   PubMed Web of Science ®Google Scholar
• Lallement G., Demoncheaux J. P., Foquin A., Baubichon D., Galonnier M., Clarencon D., Dorandeu F. Subchronic administration of pyridostigmine or huperzine to primates: compared efficacy against soman toxicity. Drug Chem. Toxicol. 2002; 25(3)309–320
   PubMed Web of Science ®Google Scholar
• Lallement G., Clarencon D., Masqueliez C., Baubichon D., Galonnier M., Burckhart M.-F., Peoc'h M., Mestries J. C. Nerve agent poisoning in primates: antilethal, anti-epileptic and neuroprotective effects of GK-11. Arch. Toxicol. 1998; 72: 84–92
   PubMed Web of Science ®Google Scholar
• Lallement G., Clarencon D., Galonnier M., Baubichon D., Burckhart M. F., Peoc'h M. Acute soman poisoning in primates neither pretreated nor receiving immediate therapy: value of gacyclidine (GK-11) in delayed medical support. Arch. Toxicol. 1999; 73: 115–122
   PubMed Web of Science ®Google Scholar
• Lallement G., Mestries J. C., Privat A., Brochier G., Baubichon D., Carpentier P., Kamenka J. M., Sentenac-Roumanou H., Burckhart M. F., Peoc'h M. GK-11: promising additional neuroprotective therapy for organophosphate poisoning. NeuroToxicol. 1997; 18: 851–856
   PubMed Web of Science ®Google Scholar
• Lallement G., Renault F., Baubichon D., Peoc'h M., Burckhart M. F., Galonnier M., Clarencon D., Jourdil N. Compared efficacy of diazepam or avizafone to prevent soman-induced electroencephalographic disturbances and neuropathology in primates: relationship to plasmatic benzodiazepine pharmacokinetics. Arch. Toxicol. 2000; 74: 480–486
   PubMed Web of Science ®Google Scholar
• Lenz D. E., Maxwell D. M., Koplovitz I., Clark C. R., Capacio B. R., Cerasoli D. M., Federko J. M., Luo C., Saxena A., Doctor B. P., Olson C. Protection against soman or VX poisoning by human butyrylcholinesterase in guinea pigs and cynomolgus monkeys. Chem. Biol. Interact. 2005; 15: 157–158, 205–210
   Google Scholar
• Lipp J. A. Cerebral electrical activity following soman administration. Arch. Int. Pharmacodyn. 1968; 175: 161–169
   PubMedGoogle Scholar
• Lipp J. A. Effect of diazepam upon soman-induced seizure activity and convulsions. EEG Clin. Neurophys. 1972; 32: 557–560
   PubMedGoogle Scholar
• Lipp J. A. Effect of benzodiazepine derivatives on soman-induced seizure activity and convulsions in the monkey. Arch. Int. Pharmacodyn. Ther. 1973; 202: 244–251
   PubMedGoogle Scholar
• Lipp J. A., Dola T. J. Effect of atropine upon the Cerebrovascular system during soman-induced respiratory depression. Arch. Int. Pharmacodyn. Ther. 1978; 235(2)211–218
   PubMedGoogle Scholar
• McDonough J. H., Jaax N. K., Crowley R. A., Mays M. Z., Modrow H. E. Atropine and/or diazepam therapy protects against soman-induced neural and cardiac pathology. Fundam. Appl. Toxicol. 1989; 13: 256–276
   PubMedGoogle Scholar
• Miller C. O. Toxicology: use of nonhuman primates. Science 1967; 156: 1772–1773
   PubMed Web of Science ®Google Scholar
• Muggleton N. G., Bowditch A. P., Crofts H. S., Scott E. A., Pearce P. C. Assessment of a combination of physostigmine and scopolamine as pretreatment against the behavioural effects of organophosphates in the common marmoset (Callithrix jacchus). Psychopharmacology (Berl). 2003; 166(3)212–220
   PubMed Web of Science ®Google Scholar
• Murphy M. P., Blick D. W., Dunn M. A., Fanton J. W., Hartgraves S. L. Diazepam as a treatment for nerve agent poisoning in primates. Aviat. Space Environ. Med. 1993; 64: 110–1105
   PubMedGoogle Scholar
• National Research Council. Guide for the Care and Use of Laboratory Animals. National Academy Press, Washington, D. C. 1996
   Google Scholar
• Olson C. T., Menton R. G., Kiser R., Matthews M., Stotts R., Romano J. R., Koplovitz I., Hackley B. E. Efficacies of atropine/2-PAM and antropine/HI-6 in treating monkeys intoxicated with organophosphonate nerve agents. Int. J. Toxicol. 1997; 16: 9–20
   Web of Science ®Google Scholar
• Philippens I. H. C. H. M., Vanwersch R. A. P., Groen B., Olivier B., Bruijnzeel P. L. B., Melchers B. P. C. Subchronic physostigmine pretreatment in marmosets: absence of side effects and effectiveness against soman poisoning with negligible postintoxication incapacitation. Toxicol. Sci. 2000; 53: 84–91
   PubMed Web of Science ®Google Scholar
• Schoen F. J. The heart. Robbins and Cotran Pathologic Basis of Disease, 7th edition, V. Kumar, A. K. Abbas, N. Fausto. W. B. Saunders, Philadelphia 2005
   Google Scholar
• Shih T. -M., Penetar D. M., McDonough J. H., Romano J. A., King J. M. Age-related differences in soman toxicity and in blood and brain regional cholinesterase activity. Brain Res. Bull. 1990; 24: 429–436
   PubMed Web of Science ®Google Scholar
• Sidell F. R. Nerve agents. Textbook of military medicine, Part I, Warfare, weaponry, and the casualty., F. R. Sidell, E. T. Takafuji, D. R. Franz. Office of the Surgeon general at TMM Publications, Walter Reed Army Medical Center, Washington, D. C. 1997
   Google Scholar
• TOSOH Medics. TOSOH AIA 600 Automated Immunoassay Analyzer. 2001, User Manual
   Google Scholar
• Tryphonas L., Clement J. G. Pathology of organophosphate poisoning revisited. Proceeding of the 1996 Med. Def. Bioscience Rev. 1996; 1: 447–456, Medical Defense Bioscience Review, United States Army Medical Research Institute of Chemical Defense, Aberdeen Proving Ground, MD. AD-A321840
   Google Scholar
• van der Schans M. J., Lander B. J., van der Wiel H., Langenberg J. P., Benschop H. P. Toxicokinetics of the nerve agent (+/-)-VX in anesthetized and atropinized hairless guinea pigs and marmosets after intravenous and percutaneous administration. Toxicol. Appl. Pharmacol. 2003; 15(191(1))48–62
   Google Scholar
• van Helden H. P., Trap H. C., Oostdijk J. P., Kuijpers W. C., Langenberg J. P., Benschop H. P. Long-term, low-level exposure of guinea pigs and marmosets to sarin vapor in air: lowest observable effect level. Toxicol. Appl. Pharmacol. 2003; 15(189(3))170–179
   Google Scholar
• van Helden H. P., Trap H. C., Kuijpers W. C., Oostdijk J. P., Benschop H. P., Langenberg J. P. Low-level exposure of guinea pigs and marmosets to sarin vapour in air: lowest-observable-adverse-effect level (LOAEL) for miosis. J. Appl. Toxicol. 2004a; 24(1)59–68
   PubMed Web of Science ®Google Scholar
• van Helden H. P. M., van Der Wiel H. J., De Lange J., Busker R. W., Melchers B. P. C., Wolthuis O. L. Therapeutic efficacy of HI-6 in soman-poisoned marmoset monkeys. Toxicol. Appl. Pharmacol. 1992; 115: 50–56
   PubMed Web of Science ®Google Scholar
• van Helden H. P., Vanwersch R. A., Kuijpers W. C., Trap H. C., Philippens I. H., Benschop H. P. Low levels of sarin affect the EEG in marmoset monkeys: a pilot study. J. Appl. Toxicol. 2004b; 24(6)475–483
   PubMed Web of Science ®Google Scholar
• von Bredow J., Corcoran K., Maitland G. Kaminskis A. Adams N., Wade J. Efficacy evaluation of physostigmine and anticholinergic adjuncts as a pretreatment for nerve agent intoxication. Fund. Appl. Toxicol. 1991; 17: 782–789
   PubMedGoogle Scholar
• Walker D. B. Serum chemical biomarkers of cardiac injury for nonclinical safety testing. Toxicol. Pathol. 2006; 34: 94–104
   PubMed Web of Science ®Google Scholar
• Wetherell J. R., French M. C. A comparison of decarbamyolation rates of physostigmine-inhibited plasma and red cell cholinesterases of man with other species. Biochem. Pharmacol. 1991; 42: 515–520
   PubMed Web of Science ®Google Scholar